Non-steroidal anti-inflammatory drugs Flashcards
Main risk of NSAIDS
Increased risk of GI and CVS deaths
Main use of NSAIDS + examples
Relief of mild-to-moderate pain (analgesic)
- toothache, headache, backache
- opioid sparing posteroperative pain
- dysmenorrhea
Reduction of fever (antipyretic)
-influenza
Reduction of inflammation (anti-inflammatory)
- Rheumatoid arthritis/osteoarthritis
- Osteoarthritis
- MSK inflammation
- Strains and sprains (soft tissue injury)
- Gout
How do NSAIDS work
What are the products of COX enzymes. What is their distribution and how are they released
Inhibition of prostaglandin and thromboxane synthesis
Lipid mediators derived from arachidonic acid
Cyclo-oxygenase enzymes
Widely distributed
Not stored or pre-formed
Receptor-mediated
Outline arichidonic acid metabolism
AA–> prostglandin H2(BY COX1&2)
–> prostacyclin, prostaglandin E2, prostaglandin D2, prostaglandin F2a, TXA2 (by specific synthases)
What are prostanoid receptors
What are they named on the basis of
How do they achieve their effect
10 known prostanoid receptors
DP1, DP2, EP1, EP2, EP3, EP4, FP, IP1,IP2, TP
Naming based on agonist potency but they are NOT completely specific
Prostanoids have both G protein-dependent and -independent effects
What are the actions of prostanoid receptors
Physiological and pro-inflammatory
How any receptors can PGE2 act on, and to what effect
PGE2 can activate 4 Receptors
cAMP-dependent and independent downstream mechanisms:
EP1 and EP3 can increase Ca2+ mobilisation
EP2& EP4 will increase cAMP activtion
EP3 downregulates cAMP, as can EP2 (can up or downregulate)
What can EP2 do
Increased pain perception Increased body temperature Acute inflammatory response Immune responses Tumorigenesis Inhibition of apoptosis
What effect does PGE2 have on pain threshold and how
PG receptors in the periphery sensitizes the nociceptors which cause pain both acutely and chronically.
HYPERALGESIA
Specific mechanism of action for reduction in pain threshold due to PGE2
- cAMP mediated…. activates P2X3 nociceptors due to PKA (this pathway occurs anyway but can increase with more PGE2 and Epac pathway can be activated too)
- EP1 receptors and/or EP4 receptors (in periphery and spine)
- Could downregulate endocannabinoids (neuromodulators in thalamus, spine and periphery)
- increasing beta-endorphin in spine
SO NSAIDS WOULD REVERSE THESE THINGS
Why do NSAIDS reduce fever
PGE2 is pyrogenic…. stimulates hypothalamic neurones initiating a rise in body temperature
(in the experiment a pyrogenic was injected, and PGE2 rose before temperature did)
What is another important role of PGE2
COMPLEX ROLE IN INFLAMMATION
What is the desirable effects of PGE2
Gastroprotection
Bronchodilation (although there is evidence that PGE2 can desensitise β2adrenoceptors)
Renal salt and water homeostasis
Vasoregulation (dilation and constriction depending on receptor activated)
Why are NSAIDS not used in asthmatics
MANY COX PRODUCTS CAUSE BRONCHODILATION, BUT (e.g. PGE2 is normally protective)
~10% asthma patients experience worsening symptoms with NSAIDS
Cyclooxygenase inhibition favours production of leukotrienes - bronchoconstrictors
But only in some asthmatics… depends on penotypes
(mouse knockouts for PGE2 had aspirin induced asthma, suggesting PGE2 is protective)
What is PGE2 production mediated by
COX1&2
How does PGE2 affect renal blood flow
How can NSAIDS cause renal toxicity
Where are COX enzymes found within the nephron
What location of COX enzymes accounts for the effect of PGE2 on renal blood flow
PGE2 increases renal blood flow
NSAIDs can cause renal toxicity:
Constriction of afferent renal arteriole –> Reduction in renal artery flow –> Reduced glomerular filtration rate
COX1 in the DCT/ collecting duct, COX2 in ALH and macula densa
COX1&2 in the glomerulus
COX-1 and COX-2 enzymes in the glomerulus causes PGE2 production which is affecting this renal blood flow
What is the role of PGE2 in gastric cytoprotection.
Which COX enzyme is this dependent on
PGE2 downregulates HCl secretion
PGE2 stimulates
mucus and bicarbonate secretion
(so increased neutralisation and increased physical barrier)
DEPENDENT ON COX 1 (howeer PGE2 is produced by COX 1 and COX 2 remember)
What is the effect of NSAIDS on the GI system
NSAIDS increase the risk of ulceration
Differentiate the COX 1 and 2
Different (but overlapping) cellular distributions
NOT the case that COX1 inhibition is phsiological and COX2 inhibition is pathological
Most NSAIDs reversibly inhibit both isoforms (example: ibuprofen)
What is the Coxib family of NSAIDS.
What is their benefit?
Coxib family: selectively reversibly inhibit COX-2 (example: celecoxib)
(hypothesised to be gastroprotective, and were, but still CVS effects)
What are the unwanted effects of NSAIDS on CVS
Vasoconstriction (as was seen in the case of renal toxicity of NSAIDS, causing vasoconstriction, it the same here but generalised)
Salt and water retention
Reduced effect of antihypertensives
Risk of HTN, MI and stroke
so even though the coxib (selective COX2 inhibitor) reduced the GI problems there was higher risk of CVS disease